ALLOGENE THERAPEUTICS INC's ticker is ALLO and the CUSIP is 019770106. A total of 97 filers reported holding ALLOGENE THERAPEUTICS INC in Q2 2019. The put-call ratio across all filers is 0.84 and the average weighting 1.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $140,651 | -93.4% | 28,300 | -91.6% | 0.00% | -100.0% |
| Q4 2022 | $2,122,246 | -77.3% | 337,400 | -1.8% | 0.01% | -57.9% |
| Q3 2019 | $9,362,000 | +1.3% | 343,510 | -0.2% | 0.02% | +5.6% |
| Q2 2019 | $9,240,000 | +209.4% | 344,116 | +233.2% | 0.02% | +50.0% |
| Q1 2019 | $2,986,000 | – | 103,285 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| VV Manager LLC | 1,798,163 | $76,997,000 | 67.53% |
| Wildcat Capital Management, LLC | 1,515,524 | $64,895,000 | 22.42% |
| TPG Group Holdings (SBS) Advisors, Inc. | 19,716,306 | $844,252,000 | 14.91% |
| REGENTS OF THE UNIVERSITY OF CALIFORNIA | 1,279,281 | $54,779,000 | 7.69% |
| Coastal Bridge Advisors, LLC | 463,117 | $19,831,000 | 6.33% |
| DSAM Partners (London) Ltd | 235,098 | $10,067,000 | 2.63% |
| Casdin Capital, LLC | 625,000 | $26,763,000 | 1.58% |
| Alpine Global Management, LLC | 150,000 | $6,423,000 | 1.13% |
| Perceptive Advisors | 1,543,790 | $66,105,000 | 1.07% |
| Avoro Capital Advisors LLC | 1,128,594 | $48,326,000 | 0.96% |